Quick Search 
Drugs of the Future
Register or sign in

  
 
  
Volume 30, Issue 5, May 2005, Pages 441-540
 
MONOGRAPHS
 
  
 Darunavir.
Anti-HIV agent, HIV protease inhibitor.
Sorbera, L.A., Castaner, J., Bayes, M.
Drugs Fut 2005, 30(5): 441
Summary | Full Text: HTMLPDF 
 
  
  
 ED-71.
Treatment of osteoporosis, Vitamin D analogue.
McIntyre, J.A., Castaner, J., Castaner, R.M., Bayes, M.
Drugs Fut 2005, 30(5): 450
Summary | Full Text: HTMLPDF 
 
  
  
 Etravirine.
Anti-HIV agent, Reverse transcriptase inhibitor.
Davies, S.L., Castaner, J., Silvestre, J.S., Bayes, M.
Drugs Fut 2005, 30(5): 462
Summary | Full Text: HTMLPDF 
 
  
  
 Maraviroc.
Anti-HIV agent, Viral entry inhibitor, Chemokine CCR5 antagonist.
Barretina Ginesta, J., Castaner, J., Bozzo, J., Bayes, M.
Drugs Fut 2005, 30(5): 469
Summary | Full Text: HTMLPDF 
 
  
 
REVIEW ARTICLES
 
  
 Drug discovery targets: 5-HT6 receptor.
Davies, S., Silvestre, J.S., Guitart, X.
Drugs Fut 2005, 30(5): 479
Summary | Full Text: HTMLPDF 
 
  
  
 Fumagillin class inhibitors of methionine aminopeptidase-2.
Bernier, S.G., Westlin, W.F., Hannig, G.
Drugs Fut 2005, 30(5): 497
Summary | Full Text: HTMLPDF 
 
  
  
 The future of antimalarials: artemisinins and synthetic endoperoxides.
Begue, J.-P., Bonnet-Delpon, D.
Drugs Fut 2005, 30(5): 509
Summary | Full Text: HTMLPDF 
 
  
 
Annual Update 2004/2005
 
  
 Treatment of hematological disorders.
N.E. Mealy, M. Bayés
Drugs Fut 2005, 30(5): 521
Summary | Full Text: HTMLPDF 
 
  
 
  



© 2020 Clarivate Analytics. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie Policy